Culmerciclib is an investigational small-molecule pharmaceutical compound developed as a cyclin-dependent kinase (CDK) inhibitor. It has been studied for its potential to interfere with cell-cycle progression and inhibit the proliferation of cancer cells.
Culmerciclib is a synthetic small-molecule compound investigated primarily in oncology research. It is designed to inhibit selected cyclin-dependent kinases involved in cellular proliferation and cell-cycle regulation.
Culmerciclib is also known by its development code CT-7001 and has been investigated as an oral anticancer agent.
Culmerciclib acts as a cyclin-dependent kinase inhibitor, interfering with kinase-mediated phosphorylation processes required for cell-cycle progression. Inhibition of these signaling pathways may suppress proliferation of cancer cells and promote cell-cycle arrest.
Culmerciclib has been investigated in oncology research, including studies involving solid tumors and other cancers where CDK-dependent signaling contributes to tumor-cell proliferation.
As an investigational compound, its development status and therapeutic applications should be described according to the applicable regulatory and clinical-development information.
Culmerciclib can be supplied for pharmaceutical research, analytical development and formulation-development applications, subject to applicable quality and regulatory requirements.
Quality evaluation may include identity, assay, related substances, residual solvents, water content, residue on ignition, elemental impurities and other applicable pharmaceutical quality attributes.
Final acceptance criteria should always be based on the approved product specification, validated analytical methods and batch-specific Certificate of Analysis (CoA).
| Parameter | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification | Conforms to Culmerciclib identity by validated analytical methods such as HPLC, LC-MS and/or IR |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.5% |
| Heavy Metals | NMT 10 ppm |
| pH (1% Solution) | 2.0 – 4.0 |
| Individual Impurity | NMT 1.0% |
| Water Content | NMT 1.0% |
| Melting Point | 150°C – 154°C |